The healthcare industry has achieved significant headways by making substantial investments in technology.
As of 2022, 91% of U.S. hospital executives reported that their organization had already implemented telemedicine. Around 56% mentioned their hospital utilizes remote patient monitoring, while around 1/4 had plans to implement it within the following year.
Here we are, 2 years later, and the bond between medicine and technology is growing stronger by the day. Tech advancements are reshaping the very essence of healthcare, but the future of the field is largely dependent on clinicians’ familiarity and control of the latest technologies shaping the field.
There are 8 key technological solutions driving innovation in the medical field and contributing to a more efficient and affordable healthcare system:
While some of these technologies are already driving the healthcare revolution forward, others have yet to demonstrate their full potential. As the bulk of Inviggo’s work revolves around healthcare software development outsourcing and designing healthtech solutions, we have been following several industry visionaries who have harnessed the power of these technologies to redefine patient care and reshape the very fabric of healthcare.
From cutting-edge robotics solutions to the groundbreaking potential of genome sequencing, here are our top 7 companies we singled out as some of the greatest instigators of medical innovation and progress.
Eligo is a Gene Editing of the Microbiome (GEM) platform used to “edit the microbiome gene repertoire in vivo”. In simpler terms, Eligo’s pioneer platform crates unique methods for sending and activating specific DNA to target harmful bacteria in the body. It allows us to directly change and adjust the types and functions of these bacteria, enabling more efficient treatments.
The Eligo platform is designed to combine a modular DNA payload with a delivery particle that can be tuned to target any bacteria. This creates space for one of the three gene editing strategies targeted at eliminating the disease-promoting gene(s) or delivering the therapeutic gene:
The in-vivo delivery of genetic cargoes to the microbiome puts them at the forefront of the field. They go beyond traditional gene therapy and editing, addressing a far wider range of generic targets, and we are excited to see how this novelty approach will help alter treatments of chronic and life-threatening diseases.
Eligo Bioscience has a portfolio of more than 25 patient families, and its revolutionary platform helps target over 100 bacterial species. They continue to drive investment capital that will allow them to create a new class of transformative genetic medicines.
Beacon Therapeutics is an ophthalmic gene therapy company built to help patients diagnosed with extremely rare and some of the most common retinal diseases resulting in blindness.
The main focus of their work is the Adeno-associated virus (AAV) gene therapy, an ocular gene therapy designed to modify cells by adding a functional copy of the genetic factor that causes the disease. As a result, the body produces proteins to treat or prevent disease progression.
Beacon Therapeutics has access to a target generation technology platform that helps identify, screen, and search secreted proteins in ophthalmology. They use subretinal and intravitreal injections, which allow for targeted delivery of AAV vectors, enhancing the treatment's safety and efficacy. The therapy has demonstrated the ability to restore gene function and deliver long-term effects.
They are currently conducting clinical trials that have shown promising results and aspire to transform retinal treatments, helping patients prevent blindness. They have seen success in treating candidates diagnosed with late-stage diseases and are conducting preclinical programs targeting dry AMD and cone-rod dystrophy (CRD).
Beacon Therapeutics has a strong clinical network, an experienced team, a state-of-the-art GMP facility, and investment backing that allows them to bring this groundbreaking tech to the ophthalmic gene therapy space.
Moon Surgical is a medical equipment manufacturing company that utilizes robotics to build devices that enable minimally invasive and digital surgery. Moon Surgical’s Maestro system assists surgeons with performing soft-tissue surgery, contributing to improved operating room efficiency and surgical care.
The platform empowers surgeons with the tools to perform safer and faster procedures, keeping operating rooms on schedule and procedure volume up. Moon Surgical’s data sets are unique in how they measure surgeons' movements. Because the surgeon is in direct control over every critical element, Maestro does exactly what the surgeon wants it to.
The system is unlike any other robotic solution that tends to keep medical personnel outside the sterile area. Moon Surgical provides the surgeon with an extra set of arms at the bedside that can be manipulated manually or autonomously. The device utilizes AI to tell the scope to follow what the surgeon is doing, giving them absolute, on-site control.
We believe Moon Surgical is on the right path to establishing a foothold in the soft tissue robotic surgery market, with the system successfully addressing the four biggest problems in the field: access, complexity, time, and cost.
Withings is world-renowned for building connected medical devices to perform comprehensive body checkups and detect anomalies on time. The idea is for everyone to be able to “see their path to better health, and feel supported to pursue it”.
They have been dominating the market with MedTech devices that make health a part of people’s everyday lives:
But what put Withings in the limelight once again is their most recent invention: U-Scan, the first hands-free connected home urine lab.
The device tracks and detects more than 100 parameters found in urine to provide instant results and actionable advice. U-Scan’s interchangeable analysis cartridges are designed to effectively assess specific parameters without external sample capture or strips to monitor users’ needs. With a detailed snapshot of the body’s balance, the system offers actionable advice that users can easily access in the Withings App.
Withings U-Scan is also the first hormonal-based cycle sync guide—a system built to measure women’s monthly hormonal fluctuations. It can evaluate nutrition and water intake and recommend advice, recipes, and activities based on the results.
They’ve come a long way since the prototype in April 2023. The product showed great results after a pilot study and usability testing, and we can’t wait to see how it will perform once it hits the market by the end of 2024.
Corti is a clinically proven software that analyzes, automates, and improves virtual care and interactions between patients and medical professionals. It is a set of tools medical professionals use to streamline repetitive and time-consuming activities like note-taking, coding, and triaging.
It is a complex system designed to support healthcare professionals delivering medical services across different levels of care. In a nutshell, Corti enhances patient and medical professionals’ experience by:
AI-powered call analysis facilitates the call review process, flagging moments for improvement and enabling a broader view of call interactions. The AI automatically collects relevant details and compiles a call summary to reduce wait times and boost call handling times. These insights help uncover trends, outcomes, and success rates.
Finally, AI analyzes the data by automating medical calling to determine the most appropriate diagnosis and procedure codes. It can also identify trends and issues in the current coding practices and flag any under- or over-coding to resolve it proactively. With accurate patient documentation comes a reduced claim denial rate and higher quality of care.
Neko Health is at the forefront of preventative medicine. It works closely with medical experts, hospitals, and universities to build next-generation technology. Its mission is to shift the focus of the entire healthcare system from reacting to symptoms to disease prevention.
Neko Health scan provides accurate, detailed, personalized, and instant insight into a patient’s health data. It combines over 70 different sensors to capture a more detailed picture of a patient’s health. It is built to examine any body part and conduct accurate measurements. It allows doctors to perform an array of medical assessments:
…and many more.
The data is securely stored in the system, and patients can easily gain updated insight from their phones anytime.
Neko Health scan enables doctors to make data-driven decisions by evaluating analysis results to offer personalized recommendations. The scan results are available immediately, and the insights are highly personalized as they stem from unique readings, not general statistical data.
Neko Health continues to advance their healthcare model, enhancing individuals' quality of life and prolonging their lifespan while lowering medical expenses.
Huma is a remote patient monitoring platform that embraces AI technology to support clinical productivity and enhance patient care. Their hospital-at-home technology collects patient data remotely, allowing medical professionals to prioritize cases based on real-time patient data.
Huma’s AI-based solution consists of two parts: an application and a web-based platform.
Patient app is an intuitive, patient-centric mobile healthcare application that encourages adherence to medical plans. It allows patients to:
Web-based dashboard was built for clinical teams to help improve patient outcomes and experience. It has been shown to double clinical capacity, reduce readmission rates, reduce backlogs, and enable early intervention. The features include:
The Huma platform is the epitome of an all-around telehealth solution that promotes proactive patient engagement and accessibility to relieve overburdened healthcare systems. It centralizes all patient data, offers valuable medical resources, and acts as a direct communication channel. It also enables connected care, accelerates research, and improves therapy.
Huma is on a mission to predict, prevent, and act proactively by building AI models, with a plan to move into evaluating the potential benefits of generative AI in healthcare.
Featured image by by Oleksandr P
